>PROKKA_00001 hypothetical protein
MGTRLKELSLMYKNNTLNKDDKKNIEYEAKSLLENMSFTIKNTKFNRKNLFNGEKLNIQG
STYNTDIKLMDFKVSKGDTIFIGNNKSSNESHTIKVSDNEIDTILKKYNLEKADKIVLYE
LEMVEEHNIKTVFTSKYGYKNNANTDIVNVSNNANKMFSINGTINDNSKVKGYLQEKDNK
LIGNININDKGYNIQLDAIMEDALKTNLNSIKTTIINKNDHTFRGNTSIIDIRDNSGMTY
IFKEITVDEFKEIIANDKSNNKNKQIVFELTNNKKCALDINSKDVNLYISDEEYNSFDIS
DILNSPNIIGEKVLSELKNYQNYIGIKTNELEYKLNFEQNNQILEETTLDKIQSIDIAKE
LVEKSKNEILVNTNAVLLQSSLENDKNYILTLLR*
>PROKKA_00002 hypothetical protein
VAKKIYSTELKLEIVKKYLSDNVSFGVLAQECNINKQDIQKCFVVYREHGEAVLSTVNGT
YYTGDFKINVVDHMHNCSARSTAAYFDIPIRGDYLDNSIMKNFFELLKFKLLYIRRI*
>PROKKA_00003 Hemagglutinin components HA-22/23/53 precursor
MNSSIKKIYNDIQEKVINYSDTIDLADGNYVVRRGDGWILSRQNQILGGSVISNGSTGIV
GDLRVNDNAIPYYYPTPSFNEEYIKNNIQTVFTNFTEANQIPIGFEFSKTAPSNKNLYMY
LQYTYIRYEIIKVLQHEIIERAVLYVPSLGYVKSIEFNPGEKINKDFYFLTNDKCILNEQ
FLYKKILETTKNIPTNNIFNSKVSSTQRVLPYSNGLYVINKGDGYIRTNDKDLIGTLLIE
AGSSGSIIQPRLRNTTRPLFTTSNDTKFSQQYTEERLKDAFNVQLFNTSTSLFKFVEEAP
SDKNICIKAYNTYEKYELIDYQNGSIVNKAEYYLPSLGYCEVTNAPSPESEVVKMQVAED
GFIQNGPEEEIVVGVIDPSENIQEINTAISDNYTYNIPGIVNNNPFYILFTVNTTGIYKI
NAQNNLPSLKIYEAIGSGNRNFQSGNLCDDDIKAINYITGFDSPNAKSYLVVLLNKDKNY
YIRVPQTSSNIENQIQFKREEGDLRNLMNSSVNIIDNLNSTGAHYYTRQSPDVHDYISYE
FTIPGNFNNKDTSNIRLYTSYNQGIGTLFRVTETIDGYNLINIQQNLHLLNNTNSIRLLN
GAIYILKVEVTELNNYNIRLHIDITN*
>PROKKA_00004 HA 17 kDa subunit
MSVERTFLPNGNYNIKSIFSGSLYLNPVSKSLTFSNESSANNQKWNVEYMAENRCFKISN
VAEPNKYLSYDNFGFISLDSLSNRCYWFPIKIAVNTYIMLSLNKVNELDYAWDIYDTNEN
ILSQPLLLLPNFDIYNSNQMFKLEKI*
>PROKKA_00005 hypothetical protein
MEHYSVIQNSLNDKIVTISCKADTNLFFYQVAGNVSLFQQTRNYLERWRLIYDSNKAAYK
IKSMDIHNTNLVLTWNAPTHNISTQQDSNADNQYWLLLKDIGNNSFIIASYKNPNLVLYA
DTVARNLKLSTLNNSNYIKFIIEDYIISDLNNFTCKISPILDLNKVVQQVDVTNLNVNLY
TWDYGRNQKWTIRYNEEKAAYQFFNTILSNGVLTWIFSNGNTVRVSSSNDQNNDAQYWLI
NPVSDTDETYTITNLRDTTKALDLYGGQTANGTAIQVFNYHGDDNQKWNIRNP*
>PROKKA_00006 transcriptional regulator BotR, P-21
MNKLFLQIKMLKNDNREFQEIFKHFEKTINIFTRKYNIYDNYNDILYHLWYTLKKVDLSN
FNTQNDLERYISRTLKRYCLDICNKRKIDKKIIYNSEIVDKKLSLIANSYSSYLEFEFND
LISILPDDQKKIIYMKFVEDIKEIDIAKKLNISRQSVYKNKIMALERLEPILKKLINM*
>PROKKA_00007 Botulinum neurotoxin type G precursor
MCVEINLGGWLDMNINDNLSINSPVDNKNVVVVRARKTDTVFKAFKVAPNIWVAPERYYG
ESLSIDEEYKVDGGIYDSNFLSQDSEKDKFLQAIITLLKRINSTNAGEKLLSLISTAIPF
PYGYIGGGYYAPNMITFGSAPKSNKKLNSLISSTIPFPYAGYRETNYLSSEDNKSFYASN
IVIFGPGANIVENNTVFYKKEDAENGMGTMTEIWFQPFLTYKYDEFYIDPAIELIKCLIK
SLYFLYGIKPSDDLVIPYRLRSELENIEYSQLNIVDLLVSGGIDPKFINTDPYWFTDNYF
SNAKKVFEDHRNIYETEIEGNNAIGNDIKLRLKQKFRININDIWELNLNYFSKEFSIMMP
DRFNNALKHFYRKQYYKIDYPENYSINGFVNGQINAQLSLSDRNQDIINKPEEIINLLNG
NNVSLMRSNIYGDGLKSTVDDFYSNYKIPYNRAYEYHFNNSNDSSLDNVNIGVIDNIPEI
IDVNPYKENCDKFSPVQKITSTREINTNIPWPINYLQAQNTNNEKFSLSSDFVEVVSSKD
KSLVYSFLSNVMFYLDSIKDNSPIDTDKKYYLWLREIFRNYSFDITATQEINTNCGINKV
VTWFGKALNILNTSDSFVEEFQNLGAISLINKKENLSMPIIESYEIPNDMLGLPLNDLNE
KLFNIYSKNTAYFKKIYYNFLDQWWTQYYSQYFDLICMAKRSVLAQETLIKRIIQKKLSY
LIGNSNISSDNLALMNLTTTNTLRDISNESQIAMNNVDSFLNNAAICVFESNIYPKFISF
MEQCINNINIKTKEFIQKCTNINEDEKLQLINQNVFNSLDFEFLNIQNMKSLFSSETALL
IKEETWPYELVLYAFKEPGNNVIGDASGKNTSIEYSKDIGLVYGINSDALYLNGSNQSIS
FSNDFFENGLTNSFSIYFWLRNLGKDTIKSKLIGSKEDNCGWEIYFQDTGLVFNMIDSNG
NEKNIYLSDVSNNSWHYITISVDRLKEQLLIFIDDNLVANESIKEILNIYSSNIISLLSE
NNPSYIEGLTILNKPTTSQEVLSNYFEVLNNSYIRDSNEERLEYNKTYQLYNYVFSDKPI
CEVKQNNNIYLTINNTNNLNLQASKFKLLSINPNKQYVQKLDEVIISVLDNMEKYIDISE
DNRLQLIDNKNNAKKMIISNDIFISNCLTLSYNGKYICLSMKDENHNWMICNNDMSKYLY
LWSFK*
>PROKKA_00008 Botulinum neurotoxin type A precursor
MPFVNKQFNYKDPVNGVDIAYIKIPNAGQMQPVKAFKIHNKIWVIPERDTFTNPEEGDLN
PPPEAKQVPVSYYDSTYLSTDNEKDNYLKGVTKLFERIYSTDLGRMLLTSIVRGIPFWGG
STIDTELKVIDTNCINVIQPDGSYRSEELNLVIIGPSADIIQFECKSFGHEVLNLTRNGY
GSTQYIRFSPDFTFGFEESLEVDTNPLLGAGKFATDPAVTLAHELIHAGHRLYGIAINPN
RVFKVNTNAYYEMSGLEVSFEELRTFGGHDAKFIDSLQENEFRLYYYNKFKDIASTLNKA
KSIVGTTASLQYMKNVFKEKYLLSEDTSGKFSVDKLKFDKLYKMLTEIYTEDNFVKFFKV
LNRKTYLNFDKAVFKINIVPKVNYTIYDGFNLRNTNLAANFNGQNTEINNMNFTKLKNFT
GLFEFYKLLCVRGIITSKTKSLDKGYNKALNDLCIKVNNWDLFFSPSEDNFTNDLNKGEE
ITSDTNIEAAEENISLDLIQQYYLTFNFDNEPENISIENLSSDIIGQLELMPNIERFPNG
KKYELDKYTMFHYLRAQEFEHGKSRIALTNSVNEALLNPSRVYTFFSSDYVKKVNKATEA
AMFLGWVEQLVYDFTDETSEVSTTDKIADITIIIPYIGPALNIGNMLYKDDFVGALIFSG
AVILLEFIPEIAIPVLGTFALVSYIANKVLTVQTIDNALSKRNEKWDEVYKYIVTNWLAK
VNTQIDLIRKKMKEALENQAEATKAIINYQYNQYTEEEKNNINFNIDDLSSKLNESINKA
MININKFLNQCSVSYLMNSMIPYGVKRLEDFDASLKDALLKYIYDNRGTLIGQVDRLKDK
VNNTLSTDIPFQLSKYVDNQRLLSTFTEYIKNIINTSILNLRYESNHLIDLSRYASKINI
GSKVNFDPIDKNQIQLFNLESSKIEVILKNAIVYNSMYENFSTSFWIRIPKYFNSISLNN
EYTIINCMENNSGWKVSLNYGEIIWTLQDTQEIKQRVVFKYSQMINISDYINRWIFVTIT
NNRLNNSKIYINGRLIDQKPISNLGNIHASNNIMFKLDGCRDTHRYIWIKYFNLFDKELN
EKEIKDLYDNQSNSGILKDFWGDYLQYDKPYYMLNLYDPNKYVDVNNVGIRGYMYLKGPR
GSVMTTNIYLNSSLYRGTKFIIKKYASGNKDNIVRNNDRVYINVVVKNKEYRLATNASQA
GVEKILSALEIPDVGNLSQVVVMKSKNDQGITNKCKMNLQDNNGNDIGFIGFHQFNNIAK
LVASNWYNRQIERSSRTLGCSWEFIPVDDGWGERPL*
>PROKKA_00009 putative transposase OrfB
MKSVIRRKRKKYIPSTSQITAENILDRNFYANKPNQKWLTDVTEFKLTDETKAYLSEILD
LHDNSIISYVLGKSNNNVLVFETFDKAVTSNPDASPLFHSDSGFQYTSKSFKNKLNEIGA
TQSMSRVGRCIDNGPMEGFWEIIKSEMYYLRKFHNFD*
>PROKKA_00010 Transposase
MRRSYDKQFKIAAVKLVLEDDMSVSDVAKDYLYIITFCIDG*
>PROKKA_00011 putative transposase OrfB
VLKKEIQQIFVENKERYGSIRIAKVLNNRGVHISRKRVSRLMEELKLYPKGIRYRYKRYN
QKSNAIERPNLLNQMFRTDKNNKIWVGDITYIPNKKGSLYLAVFLDIYSRKVVGWSMSKK
IKDTLVIDAFTQAYGKEHPSEGLIVHTDQGSQFTDGIFRVLLSKYSSVHSNSRKGNPYDN
AVMESFYRTIKRELIQDAKYETPEQAEKEIFKYIELYYNTKRIHSSLGYISPAQFENLNS
*
>PROKKA_00012 putative membrane protein
MHFCRKCGSKLQKNSKRCSTCGSELEKIHKEEISSITDRGTLLHNEIFNDEHILKHKEEP
LEIIKNFNLNKKIKENKIFLIIILILIIVGIPLMKNPIKNFFIRKDAANWLVYAVDNYKE
SDTLDTVSDFKIKSKLQPQESMEYKYIENIIEQCTLRVNNKVDKKTNERYSKVSLIHKKG
NILNGEIYSNKEYIAISMPQLYKDIMYIKWEDINKLINNKENNDVSETIDSKNYENVLNI
KKSKYYDKVNEDYKEFFNKVMDDYVAKGDTVDINIKDKENTVKCDEIVVHLDNEGIIKVL
NAFFEKVSKDENLKLLVREKVFEFLSIAQNNEDLNKFNLSKEDVDNIKREFNSEYDSFMS
ELSYIEKADKKGFNGKINSLTKVRVDSKNYIRGFKSQVSIENKKTSFNFISDTVVNSINS
KLHIKKISKEGAKDISKLTPEDRDNVVKEAANNIGKIMFPKLNIE*
>PROKKA_00013 isoaspartyl dipeptidase
LVLLIKNGKVLTMTDKKHVNDCILINNGKIEKIAKKIQTDNESIEVIDAKGGWVMPGIID
AHCHIGIMEEGIKFEGMDLNEYSSAITPHLRAIDGINPRDLAFQSAIEAGITTVMTGMGS
SNPIGGQFAIIKTYGKSVDEMVVKAPAALKIAFGENPKSIFGKKGSMPITRMGTAALIRE
TLYKAKNYMNRKEEALKEGKIFDIDIKMESIIPVLKKEIPLKAHAHRSDDILTAIRIAKE
FDLKLTIDHGTEAHLVADYIKESGFPVIAGPNMNFRGKVETKNRSYNTTKILQEKEILYA
MITDHPVVPIEFLPMSAALAVKNGLKEEDALKAITINPAKILGIEHRVGALDVGKEADIC
IYNDNPLNMNSKNMYTIISGNIVYDFNKDL*
>PROKKA_00014 hypothetical protein
MKKTSAKDFIVIGFALFAMFFGAGNLIFPPFMGKLVGDQAPAAIIGFLITGVGLPLTGII
ACAKINGTFSDISGRVGKIFAIISTTALILAIGPMLAIPRTAATTYELAIHPIFPGVAPV
VAVIIYFLVCLAFVLRPSGIVDSIGKVLTPALLVMLAIIIIKGLVSPLGPTISTGFKGAF
SKSLLEGYQTMDAMASVIFASIIITAVRAKGYTEKKDIVSLTIKSGIVAAVGLAFVYGGL
MILGSHTSQIIPGEIGRSALVVEIVKRLLGNAGTVILGLAVGLACLTTAIGLISTGAEYF
SSLTKGKVPYNVFAIIISAVSALLGTGGVDKIVKFSVPILQVLYPIVIVLIAITLAGKLV
KNNTVVRITVYTTLVVSFIDTINILTNGNVAFIKSLLGIIPLSNAGFSWLIPAVIAFIIG
TVAFGKKQDIADA*
>PROKKA_00015 hypothetical protein
MKKTSSKDFIVIGFALFAMFFGAGNLIFPPFIGNLVGDKAPIAIIGFLITGVGLPLSAII
ACAKINGTFSDISGRVGKYFSVISTTALILAIGPMLCIPRTAATTYELTVQPLFPSIGPL
VSAIIYFAICLDFVLRPSGIVDSIGKVLTPCLLLMLAIIIIKGLISPLGPVVSTNFKGVF
STSLLEGYQTMDTMGSVIYASIILASVRSKGYTDEKDVISVTIKSGIVAIAGLGLVYGGL
MVLGSQTSQIISGEEIGRTALVIEIVKRDLGNIGIVILGIAVGLACLTTAIGLLSTGAEY
LSKLTKGKVSYNAFAIIISVVSGILGIGGVDKIIKFSVPILQILYPIVIVLIVITLLGKV
VKNDSVVKFTVYITLIVSMIDTMNTLTGEKVAFIKSILGIIPLSSVGFAWLIPAIIAFII
GTIAFGNKQEKNPQAADF*
>PROKKA_00016 Hemin-binding lipoprotein
LDKHRISLTLSYSYSGFLLNLGLELCGIINKDSINQGDVVGCGPYKISEFNDEGCKLEAF
KEYFNGAPYIDIININFKSESPIDDFLNKALDVLTINDKNEYTTLCSNKNINLIEQDLLA
TYYASFNMKSNSIFSRDKDVRYALNLAIDKNRIIKDILGGLGVEAKGPFPPSIIPNNKLR
GFSHNKSKAKEILSRSDFNRSRDKLNILIRKDEDSLFSKITEYILEDLKNIGIDCIVKEV
NSSEYLNLDNILKCDMAISRWCADSGDPDNFLEPIFNIENVSNISRYDNKLVNEKLKKAK
NLINPEKRKKLYEEIQEIIVEDVPWIFLYHPKLAIAVQNNILGLNANPLGLFKYEDIIKN
*
